Symbol
| SLC6A6
| contributors: mct - updated : 19-01-2013
|
HGNC name
| solute carrier family 6 (neurotransmitter transporter, taurine), member 6
|
HGNC id
| 11052
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in spinal motor neurons of patients with ALS, and elevated expression of SLC6A6 directly contributes to increased taurine uptake in ALS motor neurons | constitutional
|  
|  
| --over
|  
|
in mononuclear peripheral blood cells of type 2 diabetic patients, while presence of retinopathy is specifically associated with a drop in SLC6A6 overexpression, suggesting its possible involvement in this microangiopathic lesion | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| is a novel pathological marker for stressed motor neurons in ALS | Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | | |
modulation of SLC6A6 and taurine may slow neuronal degeneration in ALS |
| | |
| hereditary taurine deficiency in taurine-transporter knock-out (TAUT KO) mice results in disinhibition of striatal network activity, which can be corrected by taurine supplementation |